Cargando…
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Tuberculosis is the leading infectious disease killer globally due to a single pathogen. Despite wide deployment of standard drug regimens, modern diagnostics and a vaccine (bacille Calmette Guerin, BCG), the global tuberculosis epidemic is inadequately controlled. Novel, effective vaccine(s) are a...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academic Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786643/ https://www.ncbi.nlm.nih.gov/pubmed/33279383 http://dx.doi.org/10.1016/j.smim.2020.101431 |